The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,730.00
Bid: 1,729.50
Ask: 1,730.50
Change: 1.50 (0.09%)
Spread: 1.00 (0.058%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS: Flutter Raised To Buy; Fresnillo Lowered To Sell

Mon, 08th Feb 2021 09:35

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

MORGAN STANLEY RAISES FLUTTER TO 'OVERWEIGHT' (EQUAL-WEIGHT) PRICE TARGET 17,400 (14,000) PENCE

----------

JEFFERIES CUTS UNILEVER PRICE TARGET TO 4,550 (5,350) PENCE - 'BUY'

----------

BARCLAYS CUTS UNILEVER PRICE TARGET TO 4,800 (5,500) PENCE - 'OVERWEIGHT'

----------

DZ BANK CUTS FAIR VALUE FOR UNILEVER TO 4,750 (4,850) PENCE - 'BUY'

----------

RBC RAISES JD SPORTS FASHION TO 'OUTPERFORM' (SECTOR PERFORM) - TARGET 950 (900) PENCE

----------

MORGAN STANLEY RAISES RECKITT BENCKISER PRICE TARGET TO 7,900 (7,800) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES IMPERIAL BRANDS TARGET TO 1,630 (1,600) PENCE - 'UNDERWEIGHT'

----------

UBS CUTS GLAXOSMITHKLINE PRICE TARGET TO 1,320 (1,450) PENCE - 'NEUTRAL'

----------

DZ BANK CUTS FAIR VALUE FOR GLAXOSMITHKLINE TO 1,550 (1,700) PENCE - 'BUY'

----------

CITIGROUP RAISES BHP GROUP PRICE TARGET TO 2,100 (2,000) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES ANGLO AMERICAN PRICE TARGET TO 3,000 (2,900) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS RIO TINTO PRICE TARGET TO 6,940 (7,000) PENCE - 'OVERWEIGHT'

----------

CITIGROUP RAISES RIO TINTO PRICE TARGET TO 6,000 (5,800) PENCE - 'BUY'

----------

BARCLAYS CUTS FRESNILLO PRICE TARGET TO 1,000 (1,100) PENCE - 'EQUAL WEIGHT'

----------

UBS CUTS FRESNILLO TO 'SELL' ('NEUTRAL') - TARGET 700 (1,100) PENCE

----------

BARCLAYS CUTS ANTOFAGASTA PRICE TARGET TO 1,050 (1,100) PENCE - 'UNDERWEIGHT'

----------

JEFFERIES RAISES PERSIMMON PRICE TARGET TO 3,349 (3,213) PENCE - 'BUY'

----------

JEFFERIES CUTS BARRATT DEVELOPMENTS TO 'HOLD' ('BUY') - TARGET 787 (772) PENCE

----------

BARCLAYS RAISES BARRATT DEVELOPMENTS TARGET TO 760 (725) PENCE - 'EQUAL WEIGHT'

----------

JEFFERIES RAISES TAYLOR WIMPEY TO 'BUY' ('HOLD') - TARGET 203 (156) PENCE

----------

GOLDMAN SACHS RAISES SEGRO PRICE TARGET TO 1,200 (1,110) PENCE - 'BUY'

----------

JEFFERIES RAISES SEGRO PRICE TARGET TO 999 (945) PENCE - 'HOLD'

----------

GOLDMAN RAISES NATWEST PRICE TARGET TO 270 (240) PENCE - 'BUY'

----------

GOLDMAN RAISES BARCLAYS PRICE TARGET TO 195 (180) PENCE - 'NEUTRAL'

----------

GOLDMAN RAISES LLOYDS BANKING TO 'NEUTRAL' (SELL) - PRICE TARGET 38 (33) PENCE

----------

FTSE 250

----------

PEEL HUNT INITIATES JUST GROUP WITH 'BUY' - TARGET 120 PENCE

----------

JEFFERIES RAISES VESUVIUS PRICE TARGET TO 575 (540) PENCE - 'BUY'

----------

JEFFERIES RAISES MORGAN ADVANCED MATERIALS TARGET TO 360 (300) PENCE - 'BUY'

----------

BERENBERG RAISES RENISHAW PRICE TARGET TO 6,600 (6,200) PENCE - 'BUY'

----------

BARCLAYS RAISES RENISHAW PRICE TARGET TO 5,185 (4,350) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY RAISES RENISHAW TARGET TO 5,100 (4,900) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES WEIR GROUP TO 'OVERWEIGHT' ('EQUAL-WEIGHT') - PRICE TARGET 2,200 (1,730) PENCE

----------

MORGAN STANLEY RAISES VICTREX PRICE TARGET TO 2,000 (1,700) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY RAISES SYNTHOMER TARGET TO 472 (380) PENCE - 'EQUAL-WEIGHT'

----------

BARCLAYS RAISES SPECTRIS PRICE TARGET TO 3,260 (2,940) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES KAZ MINERALS PRICE TARGET TO 900 (725) PENCE - 'OVERWEIGHT'

----------

RBC RAISES KAZ MINERALS PRICE TARGET TO 780 (640) PENCE - 'SECTOR PERFORM'

----------

GOLDMAN CUTS BABCOCK INTERNATIONAL PRICE TARGET TO 270 (290) PENCE - 'NEUTRAL'

----------

JEFFERIES RAISES MEGGITT PRICE TARGET TO 500 (375) PENCE - 'BUY'

----------

STIFEL EUROPE CUTS EASYJET TO 'SELL' (BUY) - PRICE TARGET 700 (600) PENCE

----------

RBC CUTS MARKS & SPENCER TO 'SECTOR PERFORM' (OUTPERFORM) - TARGET 150 (160) PENCE

----------

GOLDMAN RAISES ROYAL MAIL PRICE TARGET TO 470 (350) PENCE - 'BUY'

----------

JEFFERIES RAISES ROYAL MAIL PRICE TARGET TO 300 (145) PENCE - 'UNDERPERFORM'

----------

JEFFERIES RAISES BEAZLEY PRICE TARGET TO 475 (430) PENCE - 'BUY'

----------

RBC RAISES BEAZLEY PRICE TARGET TO 480 (410) PENCE - 'OUTPERFORM'

----------

PEEL HUNT CUTS LANCASHIRE HOLDINGS PRICE TARGET TO 720 (740) PENCE - 'HOLD'

----------

CREDIT SUISSE CUTS LANCASHIRE HOLDINGS TARGET TO 865 (895) PENCE - 'OUTPERFORM'

----------

GOLDMAN RAISES VIRGIN MONEY PRICE TARGET TO 155 (134) PENCE - 'NEUTRAL'

----------

JEFFERIES RAISES COUNTRYSIDE PROPERTIES PRICE TARGET TO 547 (497) PENCE - 'BUY'

----------

JEFFERIES RAISES BELLWAY PRICE TARGET TO 3,560 (3,288) PENCE - 'BUY'

----------

JPMORGAN RAISES CREST NICHOLSON PRICE TARGET TO 280 (260) PENCE - 'UNDERWEIGHT'

----------

OTHER MAIN MARKET AND AIM

----------

BARCLAYS RAISES SOUTH32 PRICE TARGET TO 130 (125) PENCE - 'UNDERWEIGHT'

----------

BARCLAYS RAISES GEM DIAMONDS PRICE TARGET TO 62 (55) PENCE - 'OVERWEIGHT'

----------

GOLDMAN RAISES THG PRICE TARGET TO 915 (885) PENCE - 'BUY'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.